Ausgabe 1/2013
Inhalt (21 Artikel)
Trastuzumab-related cardiac events in the treatment of early breast cancer
Georgeta Fried, Tslil Regev, Mor Moskovitz
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
Giselle V. Ripoll, Juan Garona, Marina Pifano, Hernan G. Farina, Daniel E. Gomez, Daniel F. Alonso
MicroRNA signatures in hereditary breast cancer
Rosa Murria Estal, Sarai Palanca Suela, Inmaculada de Juan Jiménez, Cecilia Egoavil Rojas, Zaida García-Casado, María José Juan Fita, Ana Beatriz Sánchez Heras, Ángel Segura Huerta, Isabel Chirivella González, Dolors Sánchez-Izquierdo, Marta Llop García, Eva Barragán González, Pascual Bolufer Gilabert
Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer
Louise Maymann Nitze, Elisabeth Douglas Galsgaard, Nanni Din, Vibe Luja Lund, Birgitte Bruun Rasmussen, Martin Werner Berchtold, Leif Christensen, Svetlana Panina
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
Kyle K. Payne, Christine K. Zoon, Wen Wan, Khin Marlar, Rebecca C. Keim, Mehrab Nasiri Kenari, A. Latif Kazim, Harry D. Bear, Masoud H. Manjili
Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer
Lauren S. Jammallo, Cynthia L. Miller, Marybeth Singer, Nora K. Horick, Melissa N. Skolny, Michelle C. Specht, Jean O’Toole, Alphonse G. Taghian
Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy
S. Ohno, L. W. C. Chow, N. Sato, N. Masuda, H. Sasano, F. Takahashi, H. Bando, H. Iwata, T. Morimoto, S. Kamigaki, T. Nakayama, S. Nakamura, K. Kuroi, K. Aogi, M. Kashiwaba, H. Yamashita, K. Hisamatsu, Y. Ito, Y. Yamamoto, T. Ueno, E. Fakhrejahani, N. Yoshida, M. Toi
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
Anja Welt, Mitra Tewes, Bahriye Aktas, Oliver Hoffmann, Marcel Wiesweg, Saskia Ting, Henning Reis, Karl Worm, Heike Richly, Jörg Hense, Michael R. Palmer, Benjamin H. Lee, Johanna Wendling, Josef Kossow, Max E. Scheulen, Cathrin Lehnerdt, Marzena Kohl, Cordula Derks, Silke Skottky, Ulrike Haus, Kurt W. Schmid, Rainer Kimmig, Martin Schuler, Stefan Kasper
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
David Miles, José Baselga, Dino Amadori, Patrapim Sunpaweravong, Vladimir Semiglazov, Adam Knott, Emma Clark, Graham Ross, Sandra M. Swain
Preference weights for chemotherapy side effects from the perspective of women with breast cancer
I. Kuchuk, N. Bouganim, K. Beusterien, J. Grinspan, L. Vandermeer, S. Gertler, S. F. Dent, X. Song, R. Segal, S. Mazzarello, F. Crawley, G. Dranitsaris, M. Clemons
Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
L. Eckhoff, A. S. Knoop, M.-B. Jensen, B. Ejlertsen, M. Ewertz
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with >10 % weight loss in postmenopausal women
Carol J. Fabian, Bruce F. Kimler, Joseph E. Donnelly, Debra K. Sullivan, Jennifer R. Klemp, Brian K. Petroff, Teresa A. Phillips, Trina Metheny, Sonya Aversman, Hung-wen Yeh, Carola M. Zalles, Gordon B. Mills, Stephen D. Hursting
Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case–control study in Northern Tanzania
Irmgard Jordan, Antje Hebestreit, Britta Swai, Michael B. Krawinkel
Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials
J. F. Hilton, N. Bouganim, B. Dong, J. W. Chapman, A. Arnaout, F. O’Malley, K. A. Gelmon, R. Yerushalmi, M. N. Levine, V. H. C. Bramwell, T. J. Whelan, K. I. Pritchard, L. E. Shepherd, M. Clemons
Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer
Diana S. M. Buist, Jaclyn L. F. Bosco, Rebecca A. Silliman, Heather Taffet Gold, Terry Field, Marianne Ulcickas Yood, Virginia P. Quinn, Marianne Prout, Timothy L. Lash
Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: Are there differences before and after age 40?
Erica T. Warner, Graham A. Colditz, Julie R. Palmer, Ann H. Partridge, Bernard A. Rosner, Rulla M. Tamimi
The impact of pregnancy on breast cancer survival in women who carry a BRCA1 or BRCA2 mutation
Adriana Valentini, Jan Lubinski, Tomasz Byrski, Parviz Ghadirian, Pal Moller, Henry T. Lynch, Peter Ainsworth, Susan L. Neuhausen, Jeffrey Weitzel, Christian F. Singer, Olufunmilayo I. Olopade, Howard Saal, Dominique Stoppa Lyonnet, William D. Foulkes, Charmaine Kim-Sing, Siranoush Manoukian, Dana Zakalik, Susan Armel, Leigha Senter, Charis Eng, Eva Grunfeld, Anna M. Chiarelli, Aletta Poll, Ping Sun, Steven A. Narod
Validation of Rosner–Colditz breast cancer incidence model using an independent data set, the California Teachers Study
B. A. Rosner, G. A. Colditz, S. E. Hankinson, J. Sullivan-Halley, J. V. Lacey Jr., L. Bernstein
Prospective clinical experience with research biopsies in breast cancer patients
Ines Vaz-Luis, Catherine A. Zeghibe, Elizabeth S. Frank, Jessica Sohl, Kimberly E. Washington, Stuart G. Silverman, Joseph M. Fonte, Erica L. Mayer, Beth A. Overmoyer, Andrea L. Richardson, Ian E. Krop, Eric P. Winer, Nancy U. Lin
Distinct nuclear receptor expression in stroma adjacent to breast tumors
Kevin C. Knower, Ashwini L. Chand, Natalie Eriksson, Kiyoshi Takagi, Yasuhiro Miki, Hironobu Sasano, Jane E. Visvader, Geoffrey J. Lindeman, John W. Funder, Peter J. Fuller, Evan R. Simpson, Wayne D. Tilley, Peter J. Leedman, J. Dinny Graham, George E. O. Muscat, Christine L. Clarke, Colin D. Clyne
Erratum to: CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy
Wendy A. Teft, Inna Y. Gong, Brian Dingle, Kylea Potvin, Jawaid Younus, Theodore A. Vandenberg, Muriel Brackstone, Francisco E. Perera, Yun-Hee Choi, Guangyong Zou, Robin M. Legan, Rommel G. Tirona, Richard B. Kim